These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1184595)

  • 1. Occurrence of antibodies against envelope components after immunization with formalin inactivated and live measles vaccine.
    Norrby E
    J Biol Stand; 1975; 3(4):375-80. PubMed ID: 1184595
    [No Abstract]   [Full Text] [Related]  

  • 2. Measles vaccination. VIII. The occurrence of antibodies against virus envelope components after immunization with inactivated vaccine. Effects of revaccination with live measles vaccine.
    Norrby E; Lagercrantz R
    Acta Paediatr Scand; 1976 Mar; 65(2):171-6. PubMed ID: 1258633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibody response to different measles virus antigens under various conditions of immunization.
    Norrby E; Salmi AA; Vandvik B; Hammarskjöld B; Panelius M
    Adv Exp Med Biol; 1972; 31(0):49-69. PubMed ID: 4212389
    [No Abstract]   [Full Text] [Related]  

  • 4. Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus.
    Norrby E; Enders-Ruckle G; Meulen V
    J Infect Dis; 1975 Sep; 132(3):262-9. PubMed ID: 1159329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in antibodies to the surface components of mumps virus after immunization with formalin-inactivated and live vaccines.
    Norrby E; Penttinen K
    J Infect Dis; 1978 Nov; 138(5):672-6. PubMed ID: 712121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure of attenuated viral vaccine in prevention of atypical measles.
    Chatterji M; Mankad V
    JAMA; 1977 Dec; 238(24):2635. PubMed ID: 579203
    [No Abstract]   [Full Text] [Related]  

  • 8. A REGIMEN FOR IMMUNIZATION AGAINST MEASLES. INACTIVATED VACCINE WITH DPT AND LIVE VACCINE AT AGE 9 MONTHS.
    KARELITZ S; SCHLUEDERBERG A; KANCHANAVATEE P; ARAI M; ACS H
    JAMA; 1965 Mar; 191():1067-70. PubMed ID: 14261887
    [No Abstract]   [Full Text] [Related]  

  • 9. [The characteristics of the synthesis of specific antihemagglutinins and antihemolysins in subjects inoculated with live measles vaccine in different climatic and geographical areas].
    Novitskiĭ IA; Tikhonova NT; Mamaeva TA; Dubov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (3):64-8. PubMed ID: 7941872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Persistence of immunity to attenuated measles live vaccine. V. Persistence of immunity after primary immunization with 4 strains of live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1983 Aug; 63(8):490-2. PubMed ID: 6418341
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and serological evaluation of live measles vaccine in India.
    Phadke MA; Rodrigues JJ; Mehta JM; Ayachit V
    Indian Pediatr; 1983 Aug; 20(8):573-6. PubMed ID: 6662582
    [No Abstract]   [Full Text] [Related]  

  • 12. Atypical measles in adolescent siblings 16 years after killed measles virus vaccine.
    Fulginiti VA; Helfer RE
    JAMA; 1980 Aug 22-29; 244(8):804-6. PubMed ID: 7392190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Booster vaccination with further live attenuated measles vaccine.
    Bass JW; Halstead SB; Fischer GW; Podgore JK; Pearl WR; Schydlower M; Wiebe RA; Ching FM
    JAMA; 1976 Jan; 235(1):31-4. PubMed ID: 945997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.
    Goujon C; Gougeon ML; Tondeur L; Poirier B; Seffer V; Desprès P; Consigny PH; Vray M;
    Vaccine; 2017 Oct; 35(45):6166-6171. PubMed ID: 28958813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles, mumps, rubella, and varicella.
    Isaacs D; Menser M
    Lancet; 1990 Jun; 335(8702):1384-7. PubMed ID: 1971671
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles.
    Polack FP; Lee SH; Permar S; Manyara E; Nousari HG; Jeng Y; Mustafa F; Valsamakis A; Adams RJ; Robinson HL; Griffin DE
    Nat Med; 2000 Jul; 6(7):776-81. PubMed ID: 10888926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CURRENT STATUS OF MEASLES AND ORAL POLIOVIRUS VACCINES.
    MACLEOD DR
    Can Med Assoc J; 1964 Nov; 91(21):1118-22. PubMed ID: 14229761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Persistence of immunity to attenuated measles live vaccine. VI. Observation on the results of revaccination with different vaccines via varied routes].
    Zhonghua Yi Xue Za Zhi; 1983 Sep; 63(9):541-5. PubMed ID: 6418355
    [No Abstract]   [Full Text] [Related]  

  • 19. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
    Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
    [No Abstract]   [Full Text] [Related]  

  • 20. Humoral immunity to canine distemper after immunization of dogs with inactivated and live measles virus.
    Norrby E; Appel MJ
    Arch Virol; 1980; 66(3):169-77. PubMed ID: 7447704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.